within Pharmacolibrary.Drugs.ATC.J;

model J01MA11
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.85,
    Cl             = 0.00012666666666666666,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.148,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0145,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.068,
    k12             = 10.2,
    k21             = 10.2
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01MA11</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Grepafloxacin is a fluoroquinolone antibiotic that was used for the treatment of bacterial infections, including respiratory tract infections and sexually transmitted diseases. It is no longer approved or marketed in most countries due to concerns over cardiac toxicity (QT prolongation).</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Efthymiopoulos, C (1997). Pharmacokinetics of grepafloxacin. <i>The Journal of antimicrobial chemotherapy</i> 40 Suppl A 35–43. DOI:<a href=\"https://doi.org/10.1093/jac/40.suppl_1.35\">10.1093/jac/40.suppl_1.35</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9484872/\">https://pubmed.ncbi.nlm.nih.gov/9484872</a></p></li><li><p>Efthymiopoulos, C, et al., &amp; Maroli, A (1997). Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males. <i>Clinical pharmacokinetics</i> 33 Suppl 1 1–8. DOI:<a href=\"https://doi.org/10.2165/00003088-199700331-00003\">10.2165/00003088-199700331-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9433650/\">https://pubmed.ncbi.nlm.nih.gov/9433650</a></p></li><li><p>Forrest, A, et al., &amp; Schentag, JJ (1997). Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis. <i>The Journal of antimicrobial chemotherapy</i> 40 Suppl A 45–57. DOI:<a href=\"https://doi.org/10.1093/jac/40.suppl_1.45\">10.1093/jac/40.suppl_1.45</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9484873/\">https://pubmed.ncbi.nlm.nih.gov/9484873</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01MA11;
